Cannabinoid antagonists: a treatment in search of an illness.
D'Souza
D C
DC
Department of Psychiatry, 151D, VA Connecticut Healthcare System, 950 Campbell Ave, Bldg 35, West Haven, CT 06516, USA. thomas.kosten@yale.edu
Kosten
T R
TR
D000276:Adjuvants, Immunologic / Q000627:therapeutic use; D001095:Arachidonic Acids / Q000627:therapeutic use; D002186:Cannabinoids / Q000037:antagonists & inhibitors*; D013759:Dronabinol / Q000037:antagonists & inhibitors; D063388:Endocannabinoids; D006801:Humans; D002189:Marijuana Abuse / Q000188:drug therapy*; D010880:Piperidines / Q000627:therapeutic use*; D053284:Polyunsaturated Alkamides; D011720:Pyrazoles / Q000627:therapeutic use*; D043882:Receptors, Cannabinoid; D011955:Receptors, Drug / Q000037:antagonists & inhibitors; D000077285:Rimonabant
D000276:Adjuvants, Immunologic; D001095:Arachidonic Acids; D002186:Cannabinoids; D063388:Endocannabinoids; D010880:Piperidines; D053284:Polyunsaturated Alkamides; D011720:Pyrazoles; D043882:Receptors, Cannabinoid; D011955:Receptors, Drug; D013759:Dronabinol; D000077285:Rimonabant; C078814:anandamide